Validation and modification of a diagnostic scoring system to predict microscopic colitis

Scandinavian Journal of Gastroenterology

Volumn 51, Issue 10, 2016, Pages 1206-1212

  Kane, John S ^a,b   Sood, Ruchit ^a,b   Law, Graham R ^c   Gracie, David J ^a,b   To, Natalie ^a,b   Gold, Matthew J ^b   Ford, Alexander C ^a,b  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Collagenous colitis; diarrhoea; irritable bowel syndrome; lymphocytic colitis; sensitivity; specificity

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CELIAC DISEASE; COLON BIOPSY; COLONOSCOPY; DEMOGRAPHY; DIAGNOSTIC SCORING SYSTEM; DIAGNOSTIC TEST ACCURACY STUDY; DIARRHEA; DISEASE DURATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOOSE FECES; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC COLITIS; MIDDLE AGED; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; ADOLESCENT; AGED; BIOPSY; CLASSIFICATION; COLITIS, MICROSCOPIC; COLON; PATHOLOGY; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; UNITED KINGDOM; VALIDATION STUDY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; COLITIS, MICROSCOPIC; COLON; COLONOSCOPY; DIARRHEA; FEMALE; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; UNITED KINGDOM; YOUNG ADULT;

EID: 84973115737     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365521.2016.1186221     Document Type: Article

References (23)

1. F.Magro, C.Langner, A.Driessen,. European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis. 2013;7:827–851.
2. J.Tong, Q.Zheng, C.Zhang,. Incidence, prevalence, and temporal trends of microscopic colitis: a systematic review and meta-analysis. Am J Gastroenterol. 2015;110:265–276.
3. L.Y.Chen, K.Y.Ho, K.H.Phua. Normal bowel habits and prevalence of functional bowel disorders in Singaporean adults-findings from a community based study in Bishan. Community medicine GI study group. Singapore Med J. 2000;41:255–258.
4. M.Basaranoglu, S.Celebi, H.Ataseven,. Prevalence and consultation behavior of self-reported rectal bleeding by face-to-face interview in an Asian community. Digestion. 2008;77:10–15.
5. D.A.Drossman, Z.Li, E.Andruzzi,. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993;38:1569–1580.
6. R.M.Genta, A.Sonnenberg The yield of colonic biopsy in the evaluation of chronic unexplained diarrhea. Eur J Gastroenterol Hepatol. 2015;27:963–967.
7. P.Patel, P.Bercik, D.G.Morgan,. Prevalence of organic disease at colonoscopy in patients with symptoms compatible with irritable bowel syndrome: cross-sectional survey. Scand J Gastroenterol. 2015;50:816–823.
8. E.J.Kamp, J.S.Kane, A.C.Ford Irritable bowel syndrome and microscopic colitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016;14:659–668.
9. J.S.Kane, O.Rotimi, S.M.Everett,. Development and validation of a scoring system to identify patients with microscopic colitis. Clin Gastroenterol Hepatol. 2015;13:1125–1131.
10. T.G.Cotter, M.Binder, D.S.Pardi Validation of a scoring system to predict microscopic colitis in a cohort of patients with chronic diarrhea. Clin Gastroenterol Hepatol. 2016;14:777–778.
11. E.H.Regner, M.E.Gerich Validation of a proposed scoring system to identify patients with microscopic colitis prior to colonoscopy. Am J Gastroenterol. 2015;110:S573.
12. L.Beaugerie, D.S.Pardi Review article: drug-induced microscopic colitis - proposal for a scoring system and review of the literature. Aliment Pharmacol Ther. 2005;22:277–284.
13. G.Macaigne, P.Lahmek, C.Locher,. Microscopic colitis or functional bowel disease with diarrhea: a French prospective multicenter study. Am J Gastroenterol. 2014;109:1461–1470.
14. W.E.Whitehead, and the Validation Working Team Committee in association with the Rome Questionnaire Committee. Development and validation of the Rome III diagnostic questionnaire. In: D.A.Drossman, editor. Rome III: the functional gastrointestinal disorders. 3rd ed. Virginia: Degnon Associates Inc; 2006. pp. 835–853.
15. D.Limsui, D.S.Pardi, T.C.Smyrk,. Observer variability in the histologic diagnosis of microscopic colitis. Inflamm Bowel Dis. 2009;15:35–38.
16. C.Suriya, N.Kasatpibal, W.Kunaviktikul,. Development of a simplified diagnostic indicators scoring system and validation for peptic ulcer perforation in a developing country. Clin Exp Gastroenterol. 2012;5:187–194.
17. T.A.Rockall, R.F.Logan, H.B.Devlin,. Risk assessment after acute upper gastrointestinal haemorrhage. Gut. 1996;38:316–321.
18. O.Blatchford, W.R.Murray, M.Blatchford A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet. 2000;356:1318–1321.
19. National schedule of reference costs: spell costs. https:www.//wwwgovuk/government/publications/nhs-reference-costs-2014-to-2015.
20. F.Fernandez-Banares, M.R.de Sousa, A.Salas,. Epidemiological risk factors in microscopic colitis: a prospective case-control study. Inflamm Bowel Dis. 2013;19:411–417.
21. J.K.Larsson, K.Sjoberg, L.Vigren,. Chronic non-bloody diarrhoea: a prospective study in Malmö, Sweden, with focus on microscopic colitis. BMC Res Notes. 2014;7:236.
22. A.O'Toole, A.Coss, G.Holleran,. Microscopic colitis: clinical characteristics, treatment and outcomes in an Irish population. Int J Colorectal Dis. 2014;29:799–803.
23. R.M.Lovell, A.C.Ford Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis. Am J Gastroenterol. 2012;107:991–1000.